Loading
Latest filing published 05 Jun 2026 for Assembly Biosciences, INC..
No signal scores available.
Anuj Gaggar discloses dealings in Assembly Biosciences, Inc. to SEC (Form 4). In total, 2 filings cover trades dated 29 March 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 5 June 2026 came the latest disclosure, a share grant in Assembly Biosciences, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations